ONCY Stock Analysis: Buy, Sell, or Hold?
ONCY - Oncolytics Biotech, Inc. Common Shares
$0.98
-0.03 (-2.90%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 06, 2026
Get Alerted When ONCY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called ONCY this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ONCY is down 20.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ONCY is down 20.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ONCY is currently trading at $0.98, which is considered fair relative to its 30-day fair value range of $0.92 to $1.11.
Technical Outlook: Technically, ONCY is in a strong downtrend. The price is currently testing key support at $0.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.62 (+472.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ONCY is in a strong downtrend. The price is currently testing key support at $0.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.62 (+472.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$0.92 -
$1.11
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding ONCY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 472.8% below Wall St target ($5.62)
- WARNING: Recommendation downgraded due to -20.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.92 -
$1.11
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$0.97
Resistance Level
$1.30
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.90
Wall Street Target
$5.62
(+472.8%)
Last updated: February 01, 2026 1:24 AM ET
Data refreshes hourly during market hours. Next update: 2:24 AM
Data refreshes hourly during market hours. Next update: 2:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$13 | 63 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$45 | 50 HOLD |
Advanced ONCY Option Strategies
Professional options setups generated by AI based on today's ONCY price and gamma walls.
